European Archives - Page 632 of 1108 - European Medical Journal

Talking to Dario Safaric

Dario Safaric, Chairman of the NEXT Pharma Summit, shares his journey of starting a conference from scratch, Croatia’s historical relationship with the pharmaceutical industry, and the future outlook for medical conferences in the post-COVID-19 era.

Differential Diagnosis of Nail Psoriasis and Onychomycoses: A Report Based on 40 Years of Specialised Nail Consultations

Ungual psoriasis and onychomycosis are common nail diseases. Despite their different aetiology and course, surprisingly they have much in common.

Charcot–Marie–Tooth Mutation May Prompt Novel Gene Therapy

DYSTONIN, a gene that maintains nerve cells, is now known to undergo inherited mutations that lead to a neuropathy known as Charcot–Marie–Tooth disease…

Should We Target Obesity to Avoid Alzheimer’s?

OBESITY has been linked to brain dysfunction in a large new study measuring cerebral blood flow, the primary predictor that an individual may develop Alzheimer’s disease.

EMJ Podcast: Risk-takers and Rulebreakers

This week, Jonathan Sackier chats to Dr. Dan Mahony, Co-Head Healthcare, Polar Capital. Listen now to find out more

EMJ Cardiology 8 [Supplement 2] 2020 Feature Image

EMJ Cardiology 8 [Supplement 2] 2020

The complexity of heart failure (HF) can make treatment decisions difficult, especially in those with worsening HF events…

EMJ Cardiology 8 [Supplement 2] 2020 Feature Image

Worsening Heart Failure Events Despite Foundational Therapy in Patients with Heart Failure with Reduced Ejection Fraction: An Interview with International Cardiology Experts

HF is a global problem, with an estimated 63 million patients worldwide living with the disease.4 It is projected that the lifetime risk of developing…

Talking to Nigel Adkins

Nigel Adkins, professional football manager, former player, and physiotherapist, talks about his career in football, the valuable lessons he has learnt about leadership, and the importance of routine in navigating challenging professional periods.

Type 2 Inflammation in Atopic Dermatitis and Beyond: Shared Pathophysiology and Clinical Management

EMJ Allergy & Immunology 5 [Supplement 1] 2020

Taking place at the European Academy of Allergy and Clinical Immunology (EAACI) Digital Congress 2020, the Sanofi Genzyme and Regeneron…

Type 2 Inflammation in Atopic Dermatitis and Beyond: Shared Pathophysiology and Clinical Management

Prof Maurer explored the common role of type 2 inflammation in the shared pathophysiology and epidemiology of AD and other type 2 inflammatory diseases…